GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Twareat Medical Care Company SCJSC 9627.SR · SAR

Health Care · Tadawul · 🇸🇦 Saudi Arabia

Compare

9.00

—

Close of 9 Nov 2026, in SAR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SAR, from our data supplier.

FY2025

Revenue

SAR 183.1m

FY2022FY2025

Net income

−SAR 10.3m

FY2022FY2025

Free cash flow

−SAR 6.7m

FY2022FY2025

Shareholders' equity

SAR 46.6m

FY2022FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022
RevenueSAR 183.1mSAR 191.8mSAR 154.7mSAR 149.5m
Gross profitSAR 43.9mSAR 58.8mSAR 48.3mSAR 59.2m
Operating income−SAR 7.1mSAR 25.5mSAR 14.1mSAR 26.9m
Net income−SAR 10.3mSAR 23.5mSAR 14.2mSAR 25.4m
Diluted earnings per share-0.260.590.350.64

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022
Total assetsSAR 107.9mSAR 116.8mSAR 86.5mSAR 76.5m
Cash and short-term investments—SAR 2.3mSAR 2.3mSAR 13.1m
Total liabilitiesSAR 61.3mSAR 49.6mSAR 35.1mSAR 29.2m
DebtSAR 3.4mSAR 13.1mSAR 7.6mSAR 7.9m
Shareholders' equitySAR 46.6mSAR 67.2mSAR 51.5mSAR 47.3m
Shares outstanding40m40m40m40m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022
Cash from operationsSAR 6.2mSAR 8.6mSAR 9.1mSAR 31.1m
Capital spending−SAR 12.9m−SAR 6.0m−SAR 7.6m−SAR 12.5m
Free cash flow−SAR 6.7mSAR 2.5mSAR 1.5mSAR 18.5m
Dividends paid−SAR 10.0m−SAR 8.1m−SAR 8.2m−SAR 3.2m

Latest quarters

By quarter end

Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023
RevenueSAR 92.4mSAR 90.7mSAR 99.6mSAR 92.2mSAR 83.0mSAR 71.7m
Gross profitSAR 17.4mSAR 26.4mSAR 25.4mSAR 35.2mSAR 25.5mSAR 23.6m
Operating incomeSAR 17.4mSAR 7.0mSAR 9.5mSAR 15.9mSAR 7.5mSAR 6.6m
Net income−SAR 15.8mSAR 5.5mSAR 7.4mSAR 16.1mSAR 7.6mSAR 6.5m
Diluted earnings per share-0.400.140.180.400.190.16
Cash from operations—−SAR 11.0mSAR 5.0mSAR 2.0mSAR 13.0m−SAR 4.0m
Capital spending—−SAR 2.0m−SAR 4.0m−SAR 1.0m−SAR 4.0m−SAR 3.0m
Free cash flow—−SAR 13.0mSAR 1.0mSAR 1.0mSAR 9.0m−SAR 7.0m
Total assetsSAR 107.9mSAR 133.8mSAR 116.8mSAR 105.1mSAR 86.5m—
Cash and short-term investments—SAR 1.1mSAR 2.3mSAR 2.7mSAR 2.3m—
DebtSAR 3.4mSAR 34.5mSAR 11.7mSAR 3.8mSAR 1.7m—
Shareholders' equitySAR 46.6mSAR 62.8mSAR 67.2mSAR 60.7mSAR 51.5m—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue7.0%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin27.4%30.9%——

Valuation history

At each fiscal year end

FY2025
Price to earnings-47.3
Price to sales2.7

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.